FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's supplemental application for a fixed-dose combination tablet of amlodipine and olmesartan medoxomil for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)